These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3097838)

  • 21. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New diagnostic standards in rheumatoid arthritis and recent trends in drug therapy].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):334-7. PubMed ID: 2110235
    [No Abstract]   [Full Text] [Related]  

  • 24. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug treatment of rheumatoid arthritis.
    Brooks PM
    Aust N Z J Med; 1978; 8 Suppl 1():101-5. PubMed ID: 103522
    [No Abstract]   [Full Text] [Related]  

  • 26. Organic gold compounds in the treatment of rheumatoid arthritis.
    Rooney TW; Furst DE
    Iowa Med; 1985 Feb; 75(2):74-7. PubMed ID: 3918952
    [No Abstract]   [Full Text] [Related]  

  • 27. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 29. D-penicillamine-induced increase in intracellular glutathione correlating to clinical response in rheumatoid arthritis.
    Munthe E; Kåss E; Jellum E
    J Rheumatol Suppl; 1981; 7():14-9. PubMed ID: 6785436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis].
    Nezić-Ivković J; Dürrigl T
    Reumatizam; 1978; 25(3):75-8. PubMed ID: 353935
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic interactions of penicillamine in rheumatoid arthritis.
    Seideman P; Lindström B
    J Rheumatol; 1989 Apr; 16(4):473-4. PubMed ID: 2664169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Appraisal of long-term therapy of inflammatory rheumatic diseases with tauredon, indomethacin, brufen and volon].
    Banciu M; Seceleanu A; Tiroch L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):541-8. PubMed ID: 44757
    [No Abstract]   [Full Text] [Related]  

  • 36. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. A prospective investigation.
    de Bosset PL; Biter T
    Schweiz Med Wochenschr; 1973 Aug; 103(33):1153-8. PubMed ID: 4201618
    [No Abstract]   [Full Text] [Related]  

  • 38. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.